The House Ways and Means com­mit­tee on Wednes­day marked up leg­is­la­tion that would re­quire phar­ma­cy ben­e­fit ...
Sanofi’s CSO and global head of research Frank Nestle is leaving the company, a representative confirmed to Endpoints News ...
FDA Commissioner Rob Califf told the Senate Appropriations Committee on Wednesday that milk products are safe from the H5N1 ...
BeiGene is building a fourth facility in China with a budget of $74 million for the land and construction. According to its ...
Google DeepMind and Isomorphic Labs unveiled the newest version of AlphaFold, taking its flagship AI model far beyond predicting the structure of a single protein. AlphaFold 3 can now predict a range ...
A half-decade after a scientist’s reckless experiment with human embryos put a stop to much of China’s clinical work on CRISPR gene editing, local researchers are once again performing human studies ...
Talkspace CEO Jon Cohen told investors during an earnings call Tuesday that some employers have decided to drop mental health as a benefit, a hit for a teletherapy service that sells to ...
AstraZeneca is withdrawing its Oxford-collaborated Covid-19 vaccine from global markets, the UK-based pharma company confirmed in a statement to Endpoints News on Tuesday. The spokesperson said ...
Oscar Health said Tuesday it plans to stop selling health coverage to small businesses in partnership with Cigna in 2025, as the insurance upstart doubles down on growing its footprint in the ...
The White House Office of Science and Technology Policy on Tuesday released its long-awaited policy plans for overseeing research that poses risks if misapplied. The initial reviews from experts are ...
Madrigal Pharmaceuticals is “making great progress” on the rollout of its NASH drug Rezdiffra, executives said less than a month post-launch. Rezdiffra was approved in March as the first treatment for ...
House Oversight Committee Chair James Comer (R-KY) is pressing the FDA to share more information on its presence in China amid growing concerns on Capitol Hill about Chinese involvement in biotech and ...